Form 8-K - Current report:
SEC Accession No. 0001193125-26-230425
Filing Date
2026-05-19
Accepted
2026-05-19 14:43:27
Documents
13
Period of Report
2026-05-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101911d8k.htm   iXBRL 8-K 56715
2 EX-3.1 d101911dex31.htm EX-3.1 31961
3 EX-3.2 d101911dex32.htm EX-3.2 141818
  Complete submission text file 0001193125-26-230425.txt   390011

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA medp-20260515.xsd EX-101.SCH 3165
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE medp-20260515_lab.xml EX-101.LAB 17978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE medp-20260515_pre.xml EX-101.PRE 11248
16 EXTRACTED XBRL INSTANCE DOCUMENT d101911d8k_htm.xml XML 3694
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 26997774
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)